These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 23285276

  • 1. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.
    Zhao K, Chen G, Shi XM, Gao TT, Li W, Zhao Y, Zhang FQ, Wu J, Cui X, Wang YF.
    PLoS One; 2012; 7(12):e53314. PubMed ID: 23285276
    [Abstract] [Full Text] [Related]

  • 2. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
    Dai C, Kang H, Yang W, Sun J, Liu C, Cheng G, Rong G, Wang X, Wang X, Jin Z, Zhao K.
    Carbohydr Polym; 2015 Oct 05; 130():280-9. PubMed ID: 26076628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles.
    Jin Z, Li D, Dai C, Cheng G, Wang X, Zhao K.
    Carbohydr Polym; 2017 Sep 01; 171():267-280. PubMed ID: 28578963
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine.
    Yang Y, Xing R, Liu S, Qin Y, Li K, Yu H, Li P.
    Carbohydr Polym; 2020 Feb 01; 229():115423. PubMed ID: 31826462
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA, Talaat S, Elfeil WK, Selim K, Kutkat MA, Amer SA, Choi KS.
    Poult Sci; 2020 Mar 01; 99(3):1275-1286. PubMed ID: 32111305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K, Zhang Y, Zhang X, Shi C, Wang X, Wang X, Jin Z, Cui S.
    Int J Nanomedicine; 2014 Mar 01; 9():4609-19. PubMed ID: 25356070
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
    Yang X, Zhou Y, Li J, Fu L, Ji G, Zeng F, Zhou L, Gao W, Wang H.
    Arch Virol; 2016 May 01; 161(5):1209-16. PubMed ID: 26873815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.